文献速递心血管MRUS

运动员心肌炎是挑战:诊断、风险分层与不确定性

Myocarditis in Athletes Is a Challenge: Diagnosis, Risk Stratification, and Uncertainties.
PubMed 文献 · JACC Cardiovasc Imaging · 2019-06-12

运动员心肌炎表现异质,诊断无统一临床金标准,需综合症状、心电图、实验室、超声、心脏磁共振及部分病例心内膜活检。多数患者自愈,但运动员不良心脏事件风险可能更高。当前建议基于稀少证据(主要为尸检与专家意见),推荐停止竞技运动至少3至6个月;本文对比现有推荐并提出更侧重心脏磁共振的新诊断流程图。

要点

  • 运动员心肌炎诊断无统一临床金标准,需结合症状、心电图、实验室、超声及心脏磁共振,部分病例需心内膜活检。
  • 基于稀少证据(主要为尸检与专家意见),当前推荐停止竞技运动至少3至6个月。
  • 本文提出新诊断流程图,更侧重心脏磁共振在疑似心肌炎运动员中的应用。

核心结论

  • 运动员心肌炎诊断具挑战性,现有推荐基于稀少证据;需更好风险分层工具,并提出更侧重心脏磁共振的诊断流程图以系统化咨询和统一数据。

研究设计与样本

  • 综述;基于最新可用数据对比现有推荐并提出新诊断流程图;未报告系统检索范围与纳入文献数量。

关键影像表现/征象

  • 运动员心肌炎表现异质,诊断需综合症状、心电图、实验室检查、超声心动图、心脏磁共振成像及部分病例心内膜活检。
  • 多数心肌炎患者可自愈,但运动员可能面临更高不良心脏事件风险。

诊断标准与关键数值

  • 当前推荐一般建议停止竞技运动至少3至6个月,证据主要来自尸检研究和专家意见。
  • 本文提出新诊断流程图,更侧重心脏磁共振成像在疑似心肌炎运动员中的应用。

临床应用与阅片要点

  • 作者提出新诊断流程图,更侧重心脏磁共振成像在疑似心肌炎运动员中的应用,可能使心脏照护者更系统化地咨询疑似心肌炎运动员,并有利于汇总更统一的数据。
  • 作者指出,修改运动员心肌炎的运动行为推荐需要基于大型多中心注册研究(包括心脏磁共振成像和心内膜活检)的证据。
  • 作者提出,未来医生可能依赖结合无创与有创组织特征描述的新型风险分层方法。

局限性

  • 当前推荐基于稀少证据,主要来自尸检研究和专家意见。
  • 不必要的延长运动员取消资格以避免不良心脏事件,可能对训练日程、锦标赛准备造成显著干扰,并导致运动表现和竞赛能力下降。
  • 修改运动员心肌炎运动行为推荐需要基于大型多中心注册研究(包括心脏磁共振成像和心内膜活检)的证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Presentation of myocarditis in athletes is heterogeneous and establishing the diagnosis is challenging with no current uniform clinical gold standard. The combined information from symptoms, electrocardiography, laboratory testing, echocardiography, cardiac magnetic resonance imaging, and in certain cases endomyocardial biopsy helps to establish the diagnosis. Most patients with myocarditis recover spontaneously; however, athletes may be at higher risk of adverse cardiac events. Based on scarce evidence and mainly autopsy studies and expert's opinions, current recommendations generally advise abstinence from competitive sports ranging from a minimum of 3 to 6 months. However, the dilemma poses that (un)necessary prolonged disqualification of athletes to avoid adverse cardiac events can cause considerable disruption to training schedules and tournament preparation and lead to a decline in performance and ability to compete. Therefore, better risk stratification tools are imperatively needed. Using latest available data, this review contrasts existing recommendations and presents a new proposed diagnostic flowchart putting a greater focus on the use of cardiac magnetic resonance imaging in athletes with suspected myocarditis. This may enable cardiac caregivers to counsel athletes with suspected myocarditis more systematically and furthermore allow for pooling of more unified data. To modify recommendations regarding sports behavior in athletes with myocarditis, evidence, based on large multicenter registries including cardiac magnetic resonance imaging and endomyocardial biopsy, is needed. In the future, physicians might rely on combined novel risk stratification methods, by implementing both noninvasive and invasive tissue characterization methods.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Eichhorn C, Bière L, Schnell F, et al. Myocarditis in Athletes Is a Challenge: Diagnosis, Risk Stratification, and Uncertainties. JACC Cardiovasc Imaging. 2019. PMID: 31202742. doi:10.1016/j.jcmg.2019.01.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。